These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34789839)

  • 1. CHD5 inhibits metastasis of neuroblastoma.
    Laut AK; Dorneburg C; Fürstberger A; Barth TFE; Kestler HA; Debatin KM; Beltinger C
    Oncogene; 2022 Jan; 41(5):622-633. PubMed ID: 34789839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
    Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
    J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.
    Higashi M; Kolla V; Iyer R; Naraparaju K; Zhuang T; Kolla S; Brodeur GM
    Mol Cancer; 2015 Aug; 14():150. PubMed ID: 26245651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
    Garcia I; Mayol G; Rodríguez E; Suñol M; Gershon TR; Ríos J; Cheung NK; Kieran MW; George RE; Perez-Atayde AR; Casala C; Galván P; de Torres C; Mora J; Lavarino C
    Mol Cancer; 2010 Oct; 9():277. PubMed ID: 20950435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.
    Wu X; Zhu Z; Li W; Fu X; Su D; Fu L; Zhang Z; Luo A; Sun X; Fu L; Dong JT
    Breast Cancer Res; 2012 May; 14(3):R73. PubMed ID: 22569290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein demethylates the promoter of CHD5 and inhibits neuroblastoma growth in vivo.
    Li H; Xu W; Huang Y; Huang X; Xu L; Lv Z
    Int J Mol Med; 2012 Nov; 30(5):1081-6. PubMed ID: 22960751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.
    Naraparaju K; Kolla V; Zhuang T; Higashi M; Iyer R; Kolla S; Okawa ER; Blobel GA; Brodeur GM
    Oncotarget; 2016 Mar; 7(13):15977-85. PubMed ID: 26895110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.
    Cai C; Ashktorab H; Pang X; Zhao Y; Sha W; Liu Y; Gu X
    PLoS One; 2012; 7(1):e29750. PubMed ID: 22235338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of CHD5 Inactivation in neuroblastomas.
    Koyama H; Zhuang T; Light JE; Kolla V; Higashi M; McGrady PW; London WB; Brodeur GM
    Clin Cancer Res; 2012 Mar; 18(6):1588-97. PubMed ID: 22294723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.
    Quan J; Adelmant G; Marto JA; Look AT; Yusufzai T
    PLoS One; 2014; 9(9):e108066. PubMed ID: 25247294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromodomain Helicase DNA-Binding Protein 5 Inhibits Renal Cell Carcinoma Tumorigenesis by Activation of the p53 and RB Pathways.
    Huang S; Yan Q; Xiong S; Peng Y; Zhao R; Liu C
    Biomed Res Int; 2020; 2020():5425612. PubMed ID: 33062682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
    Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
    Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.
    Xie CR; Li Z; Sun HG; Wang FQ; Sun Y; Zhao WX; Zhang S; Zhao WX; Wang XM; Yin ZY
    Oncotarget; 2015 Dec; 6(38):40940-52. PubMed ID: 26517514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHD5 is required for neurogenesis and has a dual role in facilitating gene expression and polycomb gene repression.
    Egan CM; Nyman U; Skotte J; Streubel G; Turner S; O'Connell DJ; Rraklli V; Dolan MJ; Chadderton N; Hansen K; Farrar GJ; Helin K; Holmberg J; Bracken AP
    Dev Cell; 2013 Aug; 26(3):223-36. PubMed ID: 23948251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
    Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
    Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of PIF1, a potential new target of MYCN, induces apoptosis and inhibits cell migration in neuroblastoma cells.
    Chen B; Hua Z; Gong B; Tan X; Zhang S; Li Q; Chen Y; Zhang J; Li Z
    Life Sci; 2020 Sep; 256():117820. PubMed ID: 32512012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.
    Fatemi M; Paul TA; Brodeur GM; Shokrani B; Brim H; Ashktorab H
    Cancer; 2014 Jan; 120(2):172-80. PubMed ID: 24243398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
    Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
    Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-like 1 is involved in the growth and metastasis of neuroblastoma cells.
    Wen M; Wang H; Zhang X; Long J; Lv Z; Kong Q; An Y
    Int J Oncol; 2012 Oct; 41(4):1419-24. PubMed ID: 22797702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.